Faster gastric emptying should not be relevant for BCS 1 or 3 drug products, as dissolution is rapid (or very rapid) across the physiological pH range. More rapid transit into the small intestine would therefore not be expected to result in significantly slower or incompletedissolution. A potential effect on Cmax and tmax cannot be excluded (i.e. due to gastric emptying time being more consistently at the lower end of the normal range between dosing occasions).